Literature DB >> 31668872

Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism.

Xingzhong Zhang1, Yangming Zhang1, Pengcheng Wang1, Song-Yang Zhang1, Yongqiang Dong1, Guangyi Zeng1, Yu Yan1, Lulu Sun1, Qing Wu1, Huiying Liu1, Bo Liu1, Wei Kong1, Xian Wang1, Changtao Jiang2.   

Abstract

Obesity-induced adipose dysfunction is a major contributor to atherosclerosis. Cold exposure has been reported to affect atherosclerosis through regulation of adipose function, but the mechanism has not been well clarified. Here, adipocyte hypoxia-inducible factor 2α (HIF-2α) was upregulated after mild cold exposure at 16°C and mediated cold-induced thermogenesis. Adipocyte HIF-2α deficiency exacerbated Western-diet-induced atherosclerosis by increasing adipose ceramide levels, which blunted hepatocyte cholesterol elimination and thermogenesis. Mechanistically, Acer2, the gene encoding alkaline ceramidase 2, was identified as a novel target gene of HIF-2α, triggering ceramide catabolism. Adipose overexpression of ACER2 rescued adipocyte HIF-2α-deficiency-induced exacerbation of atherosclerosis. Furthermore, activation of adipose HIF-2α by the HIF prolyl hydroxylase inhibitor FG-4592 had protective effects on atherosclerosis, accompanied by a reduction in adipose and plasma ceramide and plasma cholesterol levels. This study highlights adipocyte HIF-2α as a putative drug target against atherosclerosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIF-2α; adipocyte; atherosclerosis; ceramide

Mesh:

Substances:

Year:  2019        PMID: 31668872     DOI: 10.1016/j.cmet.2019.09.016

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  28 in total

1.  Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.

Authors:  Qing Wu; Lulu Sun; Xiaomin Hu; Xuemei Wang; Feng Xu; Bo Chen; Xianyi Liang; Jialin Xia; Pengcheng Wang; Daisuke Aibara; Shaofei Zhang; Guangyi Zeng; Chuyu Yun; Yu Yan; Yicheng Zhu; Michael Bustin; Shuyang Zhang; Frank J Gonzalez; Changtao Jiang
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 2.  Turning the Oxygen Dial: Balancing the Highs and Lows.

Authors:  Alan H Baik; Isha H Jain
Journal:  Trends Cell Biol       Date:  2020-05-05       Impact factor: 20.808

Review 3.  Contribution of specific ceramides to obesity-associated metabolic diseases.

Authors:  Philipp Hammerschmidt; Jens C Brüning
Journal:  Cell Mol Life Sci       Date:  2022-07-05       Impact factor: 9.207

4.  Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation.

Authors:  Pengcheng Wang; Guangyi Zeng; Yu Yan; Song-Yang Zhang; Yongqiang Dong; Yangming Zhang; Xingzhong Zhang; Huiying Liu; Zhipeng Zhang; Changtao Jiang; Yanli Pang
Journal:  Acta Pharm Sin B       Date:  2021-10-14       Impact factor: 14.903

5.  Alterations in gut microbiota and metabolites associated with altitude-induced cardiac hypertrophy in rats during hypobaric hypoxia challenge.

Authors:  Zhiyuan Pan; Yichen Hu; Zongyu Huang; Ni Han; Yan Li; Xiaomei Zhuang; Jiye Yin; Hui Peng; Quansheng Gao; Wenpeng Zhang; Yong Huang; Yujun Cui; Yujing Bi; Zhenjiang Zech Xu; Ruifu Yang
Journal:  Sci China Life Sci       Date:  2022-03-14       Impact factor: 10.372

6.  Metabolic View on Human Healthspan: A Lipidome-Wide Association Study.

Authors:  Justin Carrard; Hector Gallart-Ayala; Denis Infanger; Tony Teav; Jonathan Wagner; Raphael Knaier; Flora Colledge; Lukas Streese; Karsten Königstein; Timo Hinrichs; Henner Hanssen; Julijana Ivanisevic; Arno Schmidt-Trucksäss
Journal:  Metabolites       Date:  2021-04-30

7.  Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes.

Authors:  Runlu Sun; Pu Fang; Jieyu Jiang; Canxia Huang; Junjie Wang; Qi Guo; Hongwei Li; Xiaoying Wu; Xiangkun Xie; Yuan Jiang; Qian Chen; Jinlan Bao; Jingfeng Wang; Hong Wang; Yuling Zhang
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-19       Impact factor: 3.947

Review 8.  Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.

Authors:  Farzana Parveen; Daniel Bender; Shi-Hui Law; Vineet Kumar Mishra; Chih-Chieh Chen; Liang-Yin Ke
Journal:  Cells       Date:  2019-12-04       Impact factor: 6.600

9.  Transcription-Based Multidimensional Regulation of Fatty Acid Metabolism by HIF1α in Renal Tubules.

Authors:  Wenju Li; Aiping Duan; Yuexian Xing; Li Xu; Jingping Yang
Journal:  Front Cell Dev Biol       Date:  2021-07-02

10.  Intestinal MYC modulates obesity-related metabolic dysfunction.

Authors:  Yuhong Luo; Shoumei Yang; Xuan Wu; Shogo Takahashi; Lulu Sun; Jie Cai; Kristopher W Krausz; Xiaozhen Guo; Henrique B Dias; Oksana Gavrilova; Cen Xie; Changtao Jiang; Weiwei Liu; Frank J Gonzalez
Journal:  Nat Metab       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.